MedPath
HSA Approval

SITAGLIPTIN SANDOZ FILM COATED TABLET 50MG

SIN17123P

SITAGLIPTIN SANDOZ FILM COATED TABLET 50MG

SITAGLIPTIN SANDOZ FILM COATED TABLET 50MG

October 25, 2024

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A10BH01

Manufacturer Information

NOVARTIS (SINGAPORE) PTE LTD

Sandoz Private Limited

Active Ingredients

Sitagliptin phosphate Monohydrate eqv Sitagliptin

50.000 mg

Sitagliptin

Documents

Package Inserts

SITAGLIPTIN SANDOZ FILM COATED TABLET PI.pdf

Approved: October 25, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SITAGLIPTIN SANDOZ FILM COATED TABLET 50MG - HSA Approval | MedPath